Core Viewpoint - The announcement details the completion of a share buyback plan by Wang Yuling, the spouse of the company's controlling shareholder, Lin Junhua, indicating confidence in the company's future performance and stability [1][2]. Summary by Sections 1. Buyback Plan Disclosure - On April 11, 2025, the company disclosed a buyback plan where Wang Yuling intended to purchase shares worth between RMB 5 million and RMB 10 million over a six-month period starting from the announcement date [1]. 2. Implementation Results - From May 15 to May 26, 2025, Wang Yuling purchased a total of 492,300 A-shares, representing approximately 0.2962% of the company's total share capital, with a total transaction amount of RMB 6,027,173.02 (excluding transaction fees) [2][4]. - After the buyback, Lin Junhua and his concerted actions held a total of 84,593,940 shares, accounting for 50.8929% of the total share capital [2][4]. 3. Compliance and Legal Framework - The implementation of the buyback plan complies with relevant laws and regulations, including the Company Law of the People's Republic of China and the Securities Law [4][5]. - The buyback will not affect the distribution of shares required for listing, nor will it change the controlling shareholder or the governance structure of the company [5].
迈得医疗: 迈得医疗工业设备股份有限公司关于实际控制人之一致行动人增持股份结果的公告